There is a rich clinical and pre-clinical literature base demonstrating alterations in cytokine levels in AD, including but not limited to, IL-1β, IL-6, TNFα, and interferon γ (INF-γ) (reviewed in [37]). This evidence concerns the gene IL6 and Alzheimer disease.